Skip to content

Clinical trials

Withdrawn Pulmonary Embolism trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Pulmonary Embolism Status: Withdrawn Clear all

28 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20061
20071
20111
20121
20132
20142
20151
20164
20174
20182
20201
20213
20221
20242
20251
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Withdrawn28

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Pfizer2
University of California, Los Angeles2
Albert Einstein College of Medicine1
AstraZeneca1
Azienda U.S.L. 1 di Massa e Carrara1
Bayer1
Central Jutland Regional Hospital1
Centre Hospitalier Universitaire de Saint Etienne1
Daiichi Sankyo1
Echosense Ltd.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Pulmonary Embolism28
Venous Thrombosis12
Venous Thromboembolism6
Atrial Fibrillation3
Stroke3
Embolism2
Hemorrhage2
Lung Diseases2
Lung Neoplasms2
Thrombosis2

Trials

Showing 26 to 28 of 28. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.